Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 239 M
EBIT 2016 -146 M
Net income 2016 -177 M
Finance 2016 134 M
Yield 2016 -
Sales 2017 287 M
EBIT 2017 -140 M
Net income 2017 -164 M
Finance 2017 155 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 10,6x
EV / Sales 2017 8,72x
Capitalization 2 658 M
More Financials
Company
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery.It operates through two segments: Drug Discovery & Development Operations and Akcea.The Drug Discovery & Development Operations segment provides drugs to treat a variety of health conditions,... 
Sector
Biotechnology & Medical Research
Calendar
06/03 | 11:10pmShareholder meeting
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against a Late-Stage..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against Starting Lat..
05/26 IONIS PHARMACEUTICALS : Provides Update on IONIS-TTR Rx Program
05/23 IONIS PHARMACEUTICALS : Pharma (IONS), MD Anderson Enter Novel Cancer Therapeuti..
05/23 IONIS PHARMACEUTICALS : and MD Anderson Form Strategic Alliance to Advance Novel..
05/16 IONIS PHARMACEUTICALS : Akcea Therapeutics Announces Completion of Enrollment in..
05/16 INTERLEUKIN GENETICS : Reports First Quarter 2016 Financial Results
05/12 IONIS PHARMACEUTICALS : and Kastle Therapeutics Announce Acquisition of KYNAMRO®
05/12 IONIS PHARMACEUTICALS : Reports Financial Results and Highlights for First Quart..
More news
Sector news : Biotechnology & Medical Research - NEC
05/27 AMGEN : receives positive CHMP opinion to extend indication of Kyprolis
05/27 Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Pos..
05/27 Novartis, Foundation Medicine, Celgene Invest in Healthcare Informatics Firm ..
05/27 Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Scien..
05/27 MEDIVATION : Files Preliminary Consent Revocation Statement
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
2015 Game Plan For The Week - Cramer's Mad Money (12/18/15)
2015 PREMARKET BIOTECH DIGEST : Portola's Milestone, Shkreli Resigns, BioMarin DMD Dr..
2015 Isis Pharma has had enough, name changed to Ionis Pharmaceuticals
2015 Bear Afoot? No Recession Needed For A Possible Sighting
2015 PREMARKET BIOTECH DIGEST : Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Gui..
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends ISIS PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions